Perrigo (PRGO) Non-Current Deferred Tax Liability (2013 - 2026)

Perrigo (PRGO) reported Non-Current Deferred Tax Liability of $153.5 million for Q1 2026, down 18.87% year-over-year from $189.2 million in Q1 2025, and down 9.12% quarter-over-quarter from $168.9 million in Q4 2025.

Perrigo (PRGO) Non-Current Deferred Tax Liability (2013 - 2026) Analysis & Trends

Perrigo (PRGO) has 14 years of Non-Current Deferred Tax Liability data on file, last reported at $153.5 million in Q1 2026.

  • Non-Current Deferred Tax Liability for Q1 2026 came in at $153.5 million, down 18.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $153.5 million (down 18.87% YoY), and the FY2025 annual result was $168.9 million, down 65.5% from the prior year.
  • Non-Current Deferred Tax Liability slipped to $153.5 million in Q1 2026 per PRGO's latest filing, from $168.9 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $489.6 million in Q4 2024 and troughed at $153.5 million in Q1 2026.
  • A 5-year average of $280.8 million and a median of $247.7 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Deferred Tax Liability jumped 86.66% in 2024, then slumped 65.5% in 2025.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $368.2 million in 2022, then decreased by 28.76% to $262.3 million in 2023, then surged by 86.66% to $489.6 million in 2024, then tumbled by 65.5% to $168.9 million in 2025, then declined by 9.12% to $153.5 million in 2026.
  • Business Quant data shows PRGO's Non-Current Deferred Tax Liability at $153.5 million in Q1 2026, $168.9 million in Q4 2025, and $194.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Perrigo 1.55 Bn 1.19 Bn 325.50 Mn

Historic Data

Download Data
DateValue
Mar 28, 2026 153.50 Mn
Mar 28, 2026 153.50 Mn
Dec 31, 2025 168.90 Mn
Dec 31, 2025 168.90 Mn
Sep 27, 2025 194.40 Mn
Sep 27, 2025 194.40 Mn
Jun 28, 2025 206.80 Mn
Jun 28, 2025 206.80 Mn
Mar 29, 2025 189.20 Mn
Mar 29, 2025 189.20 Mn
Dec 31, 2024 489.60 Mn
Dec 31, 2024 489.60 Mn
Sep 28, 2024 213.80 Mn
Sep 28, 2024 213.80 Mn
Jun 29, 2024 211.70 Mn
Jun 29, 2024 211.70 Mn
Mar 30, 2024 247.70 Mn
Mar 30, 2024 247.70 Mn
Dec 31, 2023 262.30 Mn
Dec 31, 2023 262.30 Mn